Cargando…
Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis
BACKGROUND: Letrozole can significantly decrease the estrogen level, and has been administrated to prevent the incidence of early ovary hyperstimulation syndrome (OHSS). However, the effect of Letrozole on prevention of OHSS reached to controversial conclusions. The present meta-analysis aim to exam...
Autores principales: | Zhao, Jing, Xu, Bin, Huang, Xi, Yan, Yi, Li, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678310/ https://www.ncbi.nlm.nih.gov/pubmed/33218353 http://dx.doi.org/10.1186/s12978-020-01042-2 |
Ejemplares similares
-
The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation
por: Pritts, Elizabeth A., et al.
Publicado: (2011) -
Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023) -
Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
por: Olausson, Nina, et al.
Publicado: (2020) -
A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome
por: Chen, Yilu, et al.
Publicado: (2018) -
Relationship between follicular size and developmental capacity of oocytes under controlled ovarian hyperstimulation in assisted reproductive technologies
por: Tamura, Isao, et al.
Publicado: (2021)